SCIENION & Cellenion launch the proteoCHIP LF 48, for label-free single-cell proteomics sample preparation on the cellenONE® platform

Optimized sample preparation workflows facilitate single cell proteomics applications

4 Min
More

MDC team has explained the pivotal role of the transcription factor C/EBPb in the secretion process in the lungs’ alveoli

If a secretion in the lungs’ alveoli is not cleared regularly, breathing difficulties can develop. In a study published in Science Immunology, a team led by Alexander Mildner and Achim Leutz has now explained the pivotal role of the transcription…

4 Min
More

€7.5 million for osteoarthritis prevention

An international research consortium led by the Berlin Institute of Health at Charité (BIH) has secured funding of €7.5 million through the EU’s current Horizon Europe program. The goal of the participating scientific and clinical specialists is to…

2 Min
More

Aignostics Raises €14m Series A to Advance AI-powered Pathology

Oversubscribed financing round with top-tier life science investors, led by Wellington Partners | Spin-off from Charité – Universitätsmedizin Berlin developing sophisticated AI models to improve understanding, diagnosis and treatment of complex…

8 Min
More

NextPharma and Takeda announce Future of Pharmaceutical Manufacturing Site in Asker, Norway

- NextPharma to Acquire Takeda’s Manufacturing Site in Asker, Norway

- The Asker Site No Longer Produces Finished Products for Takeda

- Deal Closing is Expected around March 2023

3 Min
More

Neuroscientists from Charité have revealed the precise connections between sensory neurons inside the retina and a structure in the midbrain

New Neuropixels technology provides evidence of mosaic-like neural connections

 

5 Min
More

ProBioGen and City of Hope Announce Commercial License Agreement to Use AGE1.CR.pIX® Vaccine Manufacturing Platform for Cytomegalovirus (CMV) Vaccine

ProBioGen and City of Hope, one of the largest cancer research and treatment organizations in the United States, announced today a non-exclusive commercial license agreement that will allow City of Hope to manufacture its innovative synthetic…

4 Min
More

Million euro support for MyoPax

MyoPax, a new spin-off of the Max Delbrück Center and Charité, receives a 1.3 million euros loan to jump-start its entrepreneurial activities. The start-up develops regenerative therapies for previously incurable muscle diseases using its innovative…

3 Min
More

Charité study provides evidence to support suspicion that COVID-19 might trigger chronic fatigue syndrome

 

A joint press release by Charité and the MDC

Since the beginning of the pandemic, SARS-CoV-2 has been suspected of causing chronic fatigue syndrome (ME/CFS). A well-controlled study conducted by a group of researchers from Charité…

6 Min
More

Researchers from the Max Planck Institute of Colloids and Interfaces (MPICI) discovered strong adhesive properties of white-berry mistletoe

A team of researchers from the Max Planck Institute of Colloids and Interfaces (MPICI) and McGill University in Canada discovered strong adhesive properties of white-berry mistletoe. The mistletoe berry's flexible fibers adhere to both skin and…

1 Min
More
Show more items